EPIDEMIOLOGY
References continued
17. 35.
Council of the European Union. Council conclusions on reducing the burden of cancer. Ferlay J, Parkin DM, Curado MP, Bray F, Edwards BK, Shin HR, Forman D. Cancer
2876th Employment, social policy, health and consumer affairs council meeting. incidence in five continents, volumes I to IX: IARC CancerBase No. 9 [Internet].
Luxembourg, Council of the European Union, 10 June 2008. Available from: http://ci5.iarc.fr. IARC 2010. http://ci5.iarc.fr, last accessed 28 July
18.
Trubek LG, Oliver TR, Liang C-M, Mokrohisky M, Campbell T. Improving cancer 2011.
36.
outcomes through strong networks and regulatory frameworks: lessons from the Union for International Cancer Control. World Cancer Declaration. UICC 2010.
United States and the European Union. J Health Care Law Pol 2011; 14: 119-51 http://www.uicc.org/declaration/world-cancer-declaration, last accessed 28 July
19.
National Board of Health. National Cancer Plan II - Denmark. Copenhagen, Denmark, 2011.
37.
National Board of Health, 1 June 2005. Cavalli F. The World Cancer Declaration: a roadmap for change. Lancet Oncol 2008; 9:
20.
Cancer Working Group. Cancer Services - Investing for the Future (The Campbell 810-1 PM:18760235
38.
Report). Belfast, Department of Health and Social Services, 1996. World Bank. List of economies (18 July 2011). World Bank, Washington DC 2011.
21.
Department of Health. The NHS Cancer Plan. London, Department of Health, 2000. http://data.worldbank.org/about/country-classifications/country-and-lending-groups,
last accessed 3 August 2011.
22.
Department of Health. Cancer Reform Strategy. London, Department of Health, June
39.
2007. Brawley OW, Freeman HP. Race and outcomes: is this the end of the beginning for
minority health research? J Natl Cancer Inst 1999; 91: 1908-9
23.
Cancer Services Co-ordinating Group. Designed to Tackle Cancer in Wales: A Welsh
40.
Assembly Government Policy Statement. Welsh Assembly Government, December Rachet B, Woods LM, Mitry E, Riga M, Cooper C, Quinn MJ, Steward JA, Brenner H,
2006. http://www.wales.nhs.uk/sites3/Documents/322/D2TC_Strategic_ Estève J, Sullivan R, Coleman MP. Cancer survival in England and Wales at the end of
Framework_2008-11.pdf the 20th century. Br J Cancer 2008; 99 (Suppl. 1): 2-10
41.
24.
Department of Human Services. Victoria's Cancer Action Plan 2008-2011. Bach PB, Schrag D, Brawley OW, Galaznik A, Yakren S, Begg CB. Survival of blacks
Melbourne, Victoria, Victorian Government Department of Human Services, 2008. and whites after a cancer diagnosis. J Amer Med Assoc 2002; 287: 2106-13
42.
25.
Commission of Inquiry on a National Cancer Strategy. A national cancer strategy for the Brawley OW. Disaggregating the effects of race and poverty on breast cancer
future. Swedish Government Official Reports SOU 2009:11. Stockholm, Sweden, outcomes. J Natl Cancer Inst 2002; 94: 471-3 http://jnci.oxfordjournals.org
43.
Swedish Government Inquiries, 2009. Dickman PW, Gibberd RW, Hakulinen T. Estimating potential savings in cancer deaths
http://www.regeringen.se/content/1/c6/12/09/76/01389b21.pdf by eliminating regional and social class variation in cancer survival in the Nordic
26.
Rachet B, Maringe C, Nur U, Quaresma M, Shah A, Woods LM, Ellis L, Walters S, countries. J Epidemiol Comm Hlth 1997; 51: 289-98
44.
Forman D, Steward JA, Coleman MP. Population-based cancer survival trends in Abdel-Rahman MA, Stockton DL, Rachet B, Hakulinen T, Coleman MP. What if cancer
England and Wales up to 2007: an assessment of the NHS cancer plan for England. survival in Britain were the same as in Europe: how many deaths are avoidable? Br J
Lancet Oncol 2009; 10: 351-69 Cancer 2009; 101 (Suppl. 2): 115-24
27. 45.
Storm HH, Gislum M, Engholm G. [Cancer survival before and after initiating the Richards MA. The size of the prize for earlier diagnosis of cancer in England. Br J
Danish Cancer Control plan] [In Danish, English abstract]. Ugeskr Læger [Danish Cancer 2009; 101 (Suppl. 2): 125-9 http://dx.doi.org/10.1038/sj.bjc.6605402
Medical Journal] 2008; 170: 3065-9 PM:18822235 46.
Pokhrel A, Martikainen P, Pukkala E, Rautalahti M, Seppä K, Hakulinen T. Education,
28.
Rachet B, Ellis L, Maringe C, Nur U, Chu T, Quaresma M, Shah A, Walters S, Woods survival and avoidable deaths in cancer patients in Finland. Br J Cancer 2010; 103:
LM, Forman D, Coleman MP. Socioeconomic inequalities in cancer survival in England 1009-114
after the NHS Cancer Plan. Br J Cancer 2010; 103: 446-53 47.
Berrino F, Capocaccia R. Survival of European cancer patients. In: Coleman MP, Alexe
29.
Extramural Committee to Assess Measures of Progress Against Cancer. DM, Albreht T, McKee CM, eds. Responding to the challenge of cancer in Europe.
Measurement of progress against cancer. J Natl Cancer Inst 1990; 82: 825-35 Ljubljana: Institute of Public Health of the Republic of Slovenia; 2008, pp151-76.
30. 48.
Karim Kos HE, de Vries E, Soerjomataram I, Lemmens V, Siesling S, Coebergh JWW. Hawkins MM. Long term survival and cure after childhood cancer. Arch Dis Child
Recent trends of cancer in Europe: a combined approach of incidence, survival and 1989; 64: 798-807
mortality for 17 cancer sites since the 1990s. Eur J Cancer 2008; 44: 1345-89 49.
Verdecchia A, De Angelis R, Capocaccia R, Sant M, Micheli A, Gatta G, Berrino F. The
PM:18280139 cure for colon cancer: results from the EUROCARE study. Int J Cancer 1998; 77:
31.
Sant M, Francisci S, Capocaccia R, Verdecchia A, Allemani C, Berrino F. Time trends of 322-9
breast cancer survival in Europe in relation to incidence and mortality. Int J Cancer Cherie1990Sposto R. Cure models analysis in cancer: an application to data from the
2006; 119: 2417-22 Children’s Cancer Group. Stat Med 2002; 21: 293-312
32.
Coleman MP, Forman D, Bryant H, Butler J, Rachet B, Maringe C, Nur U, Tracey E, 51.
Francisci S, Capocaccia R, Grande E, Santaquilani M, Simonetti A, Allemani C, Gatta G,
Coory M, Hatcher J, McGahan CE, Turner D, Marrett L, Gjerstorff ML, Johannesen Sant M, Zigon G, Bray F, Janssen-Heijnen MLG, EUROCARE-4 Working Group. The
TB, Adolfsson J, Lambe M, Lawrence G, Meechan D, Morris EJ, Middleton R, Steward cure of cancer: a European perspective. Eur J Cancer 2009; 45 (Suppl. 6): 1067-79
J, Richards MA, ICBP Module 1 Working Group. Cancer survival in Australia, Canada,
52.
Shah A, Stiller CA, Kenward M, Vincent T, Eden TO, Coleman MP. Childhood
Denmark, Norway, Sweden, and the UK, 1995-2007 (the International Cancer
leukaemia: long-term excess mortality and the proportion ‘cured’. Br J Cancer 2008;
Benchmarking Partnership): an analysis of population-based cancer registry data.
99: 219-23
Lancet 2011; 377: 127-38
53.
http://linkinghub.elsevier.com/retrieve/pii/S0140673610622313 Woods LM, Rachet B, Lambert PC, Coleman MP. ‘Cure’ from breast cancer among
33. two populations of women followed for 23 years after diagnosis. Ann Oncol 2009; 20:
Coleman MP, Babb P, Stockton DL, Møller H, Forman D. Trends in breast cancer
1331-6
incidence, survival and mortality [Erratum in Lancet 2000;356:774]. Lancet 2000;
54.
356: 590-1 Partridge EE, Mayer-Davis EJ, Sacco RL, Balch AJ. Creating a 21st century global
34. health agenda: The General Assembly of the United Nations High Level Meeting on
Doll R, Payne P, Waterhouse JAH, eds. Cancer incidence in five continents: a technical
Non-Communicable Diseases. CA Cancer J Clin 2011; 61: 209-11 PM:21593443
report. Geneva: UICC; 1966
CANCER CONTROL 2013 65